Behar Gregory 4
4 · Seres Therapeutics, Inc. · Filed Jun 27, 2018
Insider Transaction Report
Form 4
Behar Gregory
Director
Transactions
- Award
Stock Option (right to buy)
2018-06-26+15,000→ 15,000 totalExercise: $9.09Exp: 2027-06-25→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 26, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders.